Related Experiment Video

Updated: Jul 9, 2026

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Glaucoma drainage implants in the treatment of refractory glaucoma in pediatric patients

R Autrata1, I Helmanova, H Oslejskova

  • 1Department of Pediatric Ophthalmology, Faculty of Medicine, Masaryk University Hospital, Brno, Czech Republic. rautrata@fnbrno.cz

European Journal of Ophthalmology
|December 1, 2007
PubMed

Insights

Glaucoma drainage implants (Molteno and Baerveldt) are safe and effective for pediatric glaucoma refractory to other treatments. Surgery showed sustained intraocular pressure reduction and high success rates in children.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Glaucoma Research

Background:

  • Pediatric glaucoma often requires advanced surgical interventions when medical therapy and initial surgeries fail.
  • Glaucoma drainage devices (GDDs) offer a potential solution for refractory cases.

Purpose of the Study:

  • To evaluate the clinical outcomes, efficacy, and safety of Molteno and Baerveldt glaucoma drainage implants.
  • To assess GDDs in children with primary and secondary glaucomas resistant to conventional treatments.

Main Methods:

  • Retrospective analysis of 76 children (<18 years) who received GDD implantation (1990-2004).
  • Evaluation of intraocular pressure (IOP), visual acuity, complications, and medication use.
  • Success defined by IOP (7-22 mmHg), absence of further surgery, and no vision-threatening complications.

Main Results:

  • Mean IOP decreased significantly from 33.6 mmHg preoperatively to 17.1 mmHg postoperatively.
  • Cumulative success rates ranged from 93% at 6 months to 65% at 6 years.
  • Lower age at surgery was associated with a higher risk of treatment failure; no significant difference between primary and secondary glaucoma.

Conclusions:

  • Molteno and Baerveldt glaucoma drainage implants represent a safe and effective surgical option.
  • GDD implantation provides a valuable treatment for refractory pediatric glaucoma unresponsive to prior interventions.
Abstract

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...